⌘K

Login Start Free

Home/Filings/4/0001062993-21-000138

4//SEC Filing

SAMANT VIJAY B 4

Accession 0001062993-21-000138

CIK 0000819050other

View on SEC.gov Company Profile

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 6:30 PM ET

Size

4.6 KB

Accession

0001062993-21-000138

Insider Transaction Report

Form 4

Period: 2020-12-31

Brickell Biotech, Inc.BBI

DirectorPresident & CEO

Transactions

Tax Payment
Common Stock
2020-12-31$0.78/sh−4,408$3,438→ 19,134 total

Footnotes (1)

[F1]Represents shares withheld to satisfy tax withholding obligations upon the vesting of RSUs.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Brickell Biotech, Inc.

CIK 0000819050

Entity typeother

IncorporatedDE

Related Parties

1

filerCIK 0001198238

Filing Metadata

Form type: 4
Filed: Jan 4, 7:00 PM ET
Accepted: Jan 5, 6:30 PM ET
Size: 4.6 KB

View on SEC.gov